HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arg(15,20,21)-Leu(17)- vasoactive intestinal peptide-GRR

putative drug delivery system for VIP therapy
Also Known As:
vasoactive intestinal peptide-GRR, Arg(15,20,21)-Leu(17)-; (R(15,20,21),L(17))-VIP-GRR; 15,20,21-Arg-17-Leu-VIP-GRR; IK 312532; IK-312532; IK312532; VIP-GRR, arginyl(15,20,21)-leucyl(17)-
Networked: 5 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Onoue, Satomi: 5 articles (11/2010 - 12/2004)
2. Yamada, Shizuo: 5 articles (11/2010 - 12/2004)
3. Misaka, Shingen: 3 articles (11/2010 - 09/2009)
4. Mizumoto, Takahiro: 3 articles (11/2010 - 09/2009)
5. Ohmori, Yuki: 3 articles (09/2009 - 12/2004)
6. Aoki, Yosuke: 2 articles (11/2010 - 01/2010)
7. Karaki, Shin-ichiro: 2 articles (11/2010 - 01/2010)
8. Kuwahara, Atsukazu: 2 articles (11/2010 - 01/2010)
9. Yajima, Takehiko: 2 articles (09/2009 - 12/2004)
10. Endo, Kosuke: 2 articles (12/2004 - 12/2004)

Related Diseases

1. Pheochromocytoma
2. Chronic Obstructive Pulmonary Disease (COPD)
3. Asthma (Bronchial Asthma)
4. Pneumonia (Pneumonitis)
5. Lung Diseases (Lung Disease)

Related Drugs and Biologics

1. Powders
2. Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
3. Biomarkers (Surrogate Marker)
4. Smoke
5. Peptides (Polypeptides)
6. Ovalbumin
7. Peroxidases

Related Therapies and Procedures

1. Therapeutics
2. Dry Powder Inhalers
3. Respiratory Therapy (Therapy, Respiratory)